SOLICITATION AGENT COMMON STOCK PURCHASE WARRANT Matinas BioPharma Holdings, Inc.Security Agreement • July 13th, 2026 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2026 Company Industry JurisdictionTHIS SOLICITATION AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth (5th) anniversary of the Stockholder Approval Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Matinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), up to [____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Warrant Solicitation Agent Agreement, dated as of July 10, 2026, by and between the Company and ThinkEquity
SERIES A-3 COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.Security Agreement • July 13th, 2026 • Silo Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 13th, 2026 Company IndustryTHIS SERIES A-3 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the five (5) year anniversary from the Effective Date, provided, that if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES A-4 COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.Security Agreement • July 13th, 2026 • Silo Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 13th, 2026 Company IndustryTHIS SERIES A-4 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the eighteen (18) month anniversary from the Effective Date, provided, that if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).